GlassScriptPhysician profile
Brian L Sullivan
NPI 1053395079
$1,244.35
in general payments reported to CMS, 2019-2025
27 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $43.84 · 2021: $73.71 · 2022: $204 · 2023: $241 · 2024: $265 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $167.12 | 2019-2024 | Proclaim |
| Linvatec Corporation | $126.63 | 2023 | Biobrace 23mm |
| Novo Nordisk INC | $113.76 | 2019-2023 | Wegovy |
| Smith+Nephew, INC. | $111.26 | 2021-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $78.12 | 2020-2023 | Triathlon |
| Depuy Synthes Sales INC. | $65.93 | 2022-2023 | Monovisc |
| Zimmer Biomet Holdings, INC. | $63.67 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Ferring Pharmaceuticals INC. | $49.52 | 2019-2025 | Euflexxa |
| Bone Support INC. | $46.16 | 2021 | |
| Radius Health, INC. | $46.04 | 2019 | |
| Ermi LLC | $36.90 | 2023 | |
| Corcept Therapeutics | $36.54 | 2024 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $35.35 | 2022 | |
| Bioventus LLC | $27.87 | 2022 | |
| Providence Medical Technology, INC. | $26.54 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $25.33 | 2025 | |
| Exact Sciences Corporation | $23.79 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $22.25 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $19.49 | 2024 | Crysvita |
| Fidia Pharma USA INC. | $19.23 | 2025 | Hymovis, Triluron |
| Astrazeneca Pharmaceuticals LP | $18.51 | 2024 | Farxiga |
| Medtronic, INC. | $17.39 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.80 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $14.56 | 2024 | Auvelity |
| Endo Pharmaceuticals INC. | $14.02 | 2019 | |
| Horizon Therapeutics Plc | $11.99 | 2019 | |
| Forte Bio-Pharma LLC | $10.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.